Wanwu Capital
VC Fund
Beijing, China
Wanwu Capital is an investment firm
- Total investments:
- 27
- Last investment:
- Lead investor:
- 22%
Last updated:
For AI agents: llms.txt
Industries Wanwu Capital invests in
Stages Wanwu Capital invests in
Countries Wanwu Capital invests in
Round sizes
Round size
- Seed
- $10M–$60M
- Series A
- $14M–$31M
- Venture - Series Unknown
- $20M–$38M
Investment Focus
Industry
- Artificial Intelligence 7 (26%)
- Robotics 4 (15%)
- Manufacturing 4 (15%)
- Electronics 3 (11%)
- Biotechnology 3 (11%)
Stage
- Series A 8 (30%)
- Seed 7 (26%)
- Venture - Series Unknown 4 (15%)
- Angel 2 (7%)
- Series B 2 (7%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Shanmu SHANMU is a micro medical robot specialist who uses self-developed digital microfluidic chipsets and artificial intelligence algorithms. The robot can continuously check the metabolic components in urine, establishing a link between the user's health status and disease and intelligently establishing multiple disease management cycles. | $14.7M / Series A / May 06, 2026 | ||
| VelaVigo is a start-up company engaged in macromolecular biopharmaceuticals. | $60M / Seed / Jul 28, 2025 | ||
ViTai Robotics
|
ViTai develops hand-eye coordination algorithms and general-purpose tactile sensing modules for robotic end-effectors. | $13.7M / Seed / Apr 14, 2025 | |
| Vision Intelligence is a AI smart hardware company that manufactures and sells interactive intelligence based electronic consumer products. | Seed / Jan 22, 2025 | ||
| VelaVigo is a start-up company engaged in macromolecular biopharmaceuticals. | $50M / Seed / Dec 31, 2024 | ||
| Lingsheng Technology is a developer of embodied intelligent robots. | Seed / Oct 28, 2024 | ||
| Positive Sequence Biology is a biotech company with new gene system-based editing, focused on biotech innovation & breakthrough therapies. | $13.9M / Series A / Aug 08, 2024 | ||
| Shanmu SHANMU is a micro medical robot specialist who uses self-developed digital microfluidic chipsets and artificial intelligence algorithms. The robot can continuously check the metabolic components in urine, establishing a link between the user's health status and disease and intelligently establishing multiple disease management cycles. | Seed / Jun 07, 2024 | ||
| SpacemiT is a computing chip company developing natively integrated cloud-edge-device architecture. It focuses on building RISC-V high-performance CPUs and providing computing solutions with integrated hardware and software optimization. The company's mission is to be the cornerstone of computing power in the digital age, driven to become asignificant global computing powerhouse. | Series A / Aug 04, 2023 | ||
| Mol Breeding is a biotech firm that focuses on animal and plants molecular breeding technology R&D and services. | $14.5M / Series A / Feb 21, 2023 | ||
| See all 27 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Wanwu Capital invest in?
Wanwu Capital invests primarily in Artificial Intelligence, Robotics and Manufacturing startups, most often at Series A and Seed stage. Most of the 27 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Wanwu Capital's check size?
Wanwu Capital typically joins rounds of $10M–$60M at Seed, $14M–$31M at Series A and $20M–$38M at Venture - Series Unknown. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Wanwu Capital participates in.
When did Wanwu Capital last invest?
The most recent investment recorded for Wanwu Capital closed in May 2026. Shizune tracks 27 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
